# Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

> clinical trial · VERIFIED · 2026-08-14

Status: RECRUITING · Sponsor: Insmed Incorporated · Condition: Pulmonary Hypertension

- Company: Insmed Incorporated
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07179380

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.